GB1078939A - Diagnostic reagent - Google Patents

Diagnostic reagent

Info

Publication number
GB1078939A
GB1078939A GB5168864A GB5168864A GB1078939A GB 1078939 A GB1078939 A GB 1078939A GB 5168864 A GB5168864 A GB 5168864A GB 5168864 A GB5168864 A GB 5168864A GB 1078939 A GB1078939 A GB 1078939A
Authority
GB
United Kingdom
Prior art keywords
hcg
antibody
diagnostic reagent
animal
drop
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5168864A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Publication of GB1078939A publication Critical patent/GB1078939A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB5168864A 1964-08-12 1964-12-18 Diagnostic reagent Expired GB1078939A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38917764A 1964-08-12 1964-08-12
US47899965A 1965-08-11 1965-08-11

Publications (1)

Publication Number Publication Date
GB1078939A true GB1078939A (en) 1967-08-09

Family

ID=27012580

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5168864A Expired GB1078939A (en) 1964-08-12 1964-12-18 Diagnostic reagent
GB4451865A Expired GB1086478A (en) 1964-08-12 1965-10-20 Anti-protein to human chorionic gonadotrophin

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4451865A Expired GB1086478A (en) 1964-08-12 1965-10-20 Anti-protein to human chorionic gonadotrophin

Country Status (2)

Country Link
BE (1) BE684708A (enExample)
GB (2) GB1078939A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353858A1 (fr) * 1976-06-01 1977-12-30 Warner Lambert Co Test de grossesse par agglutination directe
FR2366569A1 (fr) * 1976-09-29 1978-04-28 Mochida Pharm Co Ltd Procede immunochimique et reactifs pour le dosage d'haptene

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310508A (en) * 1979-06-19 1982-01-12 Siber George Diagnostic test and reagent therefor

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353858A1 (fr) * 1976-06-01 1977-12-30 Warner Lambert Co Test de grossesse par agglutination directe
FR2366569A1 (fr) * 1976-09-29 1978-04-28 Mochida Pharm Co Ltd Procede immunochimique et reactifs pour le dosage d'haptene

Also Published As

Publication number Publication date
BE684708A (enExample) 1967-01-30
GB1086478A (en) 1967-10-11

Similar Documents

Publication Publication Date Title
NL158937B (nl) Werkwijze voor het bepalen van een proteine of polypeptide in een waterig monster door een reactie met antilichamen, alsmede reagenspakket voor het uitvoeren van deze bepalingen.
GB1322000A (en) Preparation of antiserum specific for a carcinoembryonic antigen
ES453609A1 (es) Metodo para preparar un reactivo que se aglutina al ponerse en contacto con fluidos que contienen gonadotropina corioni-ca humana.
NL181816C (nl) Werkwijze en reagens voor de specifieke bepaling van kreatinine.
GB1083683A (en) Diagnostic agents
SE7614183L (sv) Forfarande och anordning ffor graviditetstest
GB1036592A (en) Reagents
ES444543A1 (es) Metodo de determinacion inmunologica.
GB1078939A (en) Diagnostic reagent
EP0124779A3 (de) Radioimmunverfahren für Thymosin beta 4
GB1505400A (en) Immunological diagnostic products
DK129253B (da) Reagens til påvisning af menneske-chorion-gonadotropin i urin samt fremgangsmåde til fremstilling heraf.
GB1009896A (en) Improved pregnancy test and reagent therefor
Jensen The life cycle of the fish acanthocephalan, Pomphorhynchus bulbocolli (Linkins) Van Cleave 1919, with some observations on larval development in vitro
IE36864B1 (en) Animal husbandry
GB987784A (en) A process for the separation of protein antigens from protein mixtures and the production of antisera therefor
Danielsson The demonstration of N. gonorrhoeae with the aid of fluorescent antibodies. 6. A comparison of conventional methods and fluorescent antibody (FA) techniques with counterstaining for the demonstration of N. gonorrhoeae
ES405388A1 (es) Procedimiento de ensayo para determinar la presencia de an-tigeno de australia de una muestra de sangre.
GB1516591A (en) Pregnancy testing
GB1155365A (en) Immunological Reaction
JPS562554A (en) Measuring method for hapten
ATE144147T1 (de) Wechselwirkungssystem, das eine antikörper oder antikörperfragment enthaltende, mit einem oberflächenaktiven stoff stabilisierte dispergierte wässerige phase enthält
Friedemann et al. Quantitative studies on the neutralization of pathogenic agents in tissues by circulating antibodies; quantitative determination of the effect of the substances modifying capillary permeability with the aid of indirect test
Greensher et al. Screening of newborns for sex chromosomal abnormalities by a fluorescent technique
ES496099A0 (es) Procedimiento para la fabricacion de indicadores para la go-nadotropina corionica humana